Investors hoping to buy shares in the world’s largest artificial intelligence (AI) company during its public debut this week faced more than the usual challenges of opening a brokerage account.
Investors who cleared Fidelity’s eligibility gate saw Anthropic (ANT) open at $111.50 on November 19 before closing its first session at $97.17, up 17% from the $83 IPO price.
Fidelity customers had to meet specific eligibility requirements, follow strict confirmation deadlines, and compete for limited share allocations, with no guarantee of securing shares.
Also Read: Anthropic faces a junk rating that could cost IPO investors
Anthropic priced its initial public offering (IPO) at $83 per share, raising about $81.3 billion in the largest listing on record, CNN reported.
Despite strong demand for the offering, many retail investors were uncertain whether they would receive shares at the initial price.
Fidelity outlined a nine-step process for participating in the IPO, but several important details could determine who qualified and who missed out.
Anthropic’s record IPO reshapes Wall Street’s debut rankings
Anthropic’s concluded share price is higher than the initial $70 to $78 range stated in the November 10, 2026 prospectus. The amount raised surpassed SpaceX’s $75 billion June debut, which had held the all-time IPO record.
The pricing valued the company above its most recent private funding round, which closed in May 2026 and fetched $965 billion, according to its press release.
Anthropic upsized the offering at pricing, selling about 980 million shares, up from the 825 million-share base deal in its prospectus.
Trading began under ticker ANT on the Nasdaq Global Select Market after the Securities and Exchange Commission (SEC) declared the registration statement effective on pricing night.
Dan Ives, a Partner and Senior Managing Director and Tech Analyst at Yorkville Ives, told the Associated Press that Anthropic’s listing marks the end of a multi-year drought and could signal the trigger for a new wave of tech IPO filings.
<strong>An opening of the floodgates for the IPO market, which has been relatively dormant for a few years,</strong>
The debut reopened a pipeline for AI listings that had stalled while private capital kept Anthropic and its rivals off public markets longer.
Why retail demand surged ahead of Anthropic’s Nasdaq listing
Anthropic reported run-rate revenue of about $81 billion as of October 31, 2026, a figure the company flagged in its amended prospectus.
The company disclosed about $900.9 billion in aggregate compute and infrastructure commitments, giving public investors confidence in Anthropic’s locked-in capacity.
More IPO:
Anthropic’s IPO comes with an unusual warning on AI’s risk to humanity
Anthropic’s Elvis lawsuit could reach inside Claude itself
Anthropic faces a junk rating that could cost IPO investors
Fidelity cut its permanent IPO eligibility threshold to $25,000 from a prior range of $100,000 to $500,000, its second reduction in 2026, broadening retail access to such deals, as announced on its X page.
The company’s revenue trajectory, up from a $65 billion run rate in July 2026, according to Bloomberg, drew intense buyer interest, lifting pricing above the stated range, the SEC showed.
Bloomberg reported on November 12, 2026, that Anthropic’s IPO order book reached roughly six times the number of shares available, a sign of strong investor demand.
Oversubscription at that scale typically means underwriters allocate small lots to most retail requests, leaving even eligible participants with far fewer shares than ordered.
Anthropic’s IPO attracted sixfold demand as soaring revenue, massive infrastructure commitments, and Fidelity’s lower eligibility threshold expanded retail investor participation.picture alliance / Getty Images
The nine Fidelity steps that decided who got Anthropic shares
Fidelity customers needed at least $25,000 in certain qualifying assets, with institutional accounts such as annuities and 401(k) plans excluded.
The first step was to sign up for IPO alerts on the new-issue calendar so customers are notified when offerings like Anthropic appear.
The second step was to click Participate on the Anthropic offering once it appeared on the calendar page, before moving to account selection.
For the third step, applicants selected the brokerage account intended to hold any allocated shares before proceeding to the eligibility checks.
The fourth step was to download and open the Anthropic prospectus within the participation flow, even for those who had already reviewed it on the calendar.
The fifth step asked applicants to answer the Rule 5130 and 5131 questions, which screen out restricted investors, such as broker-dealer employees.
The sixth step involved submitting an indication of interest stating the maximum share quantity the applicant would accept at the final offer price.
The seventh step allowed adjustments to indications on the Indications of Interest tab before the window closed at 4 p.m. on November 17.
While Fidelity’s Anthropic request window closed November 17 at 4 p.m. ET, two days before ANT began trading, the eligibility and allocation structure the broker set out offers a template for how retail investors will approach the next wave of AI listings.
The eighth step came after pricing, usually after 7 p.m. ET, when confirmation turned the indication into a buy order.
The ninth step was to check Activity and Orders for allocation the next morning before 9:30 a.m. ET.
All nine steps appear in Fidelity’s IPO participation guide for the Anthropic offering.
What comes next for ANT shares after the record IPO
Investors who secured Anthropic shares at the $83 IPO price now face a different market, where Nasdaq buyers set the price.
Those buying shares after the listing avoid Fidelity’s eligibility requirements and allocation process, but they also lose the price certainty IPO participants enjoyed.
Another challenge could emerge as early investors gain permission to sell their holdings. Anthropic’s prospectus outlines 23 separate lockup release dates, starting with as many as 316 million shares becoming eligible for sale on the first release day.
By February 2, 2027, the number of shares eligible for sale could reach 1.61 billion, before expanding to 3 billion by May 17, 2027. These releases could increase the supply of shares available to buyers and put pressure on ANT’s market price.
Fidelity also cautions that IPO investments remain speculative and may not suit every investor, even those who successfully receive an allocation.
For ANT, the bigger test will come next spring, when newly eligible shares could meet continued retail demand and reshape trading conditions.
Related: Anthropic’s IPO brings a warning retirees can’t afford to ignore
